Collegium Pharmaceutical Inc（COLL）價格預測COLLCollegium Pharmaceutical Inc

Alphio's COLL stock price prediction model matches the current Collegium Pharmaceutical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $24.25 (-0.19%). The 1-week path is $24.81 (+2.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Collegium Pharmaceutical Inc is not a good buy right now due to significant recent declines and negative sentiment. The current price is $25.35, which is down 44.32% year-to-date, and the RSI is at a very low 19.302, indicating oversold conditions but also a lack of buying momentum. The company's recent Q2 earnings showed a revenue of $199.9 million, which missed expectations of $201.2 million, highlighting ongoing challenges in the pain business. Additionally, insider selling has increased by 145.95% over the last month, suggesting a lack of confidence from those closest to the company. The main risk is the company's declining performance in its pain franchise, which has faced pricing pressures, contributing to a negative outlook.

Collegium Pharmaceutical Inc (COLL) last closed at $24.3, gaining +1.25%. These facts feed the 1-day and 1-week COLL price prediction above.